This site contains promotional content intended for Healthcare Professionals in Ireland and other relevant decision makers | Not a HCP? Visit our Public Site.
Adverse Event reporting can be found at the bottom of the page | Prescribing Information for the relevant medicine can be found adjacent to the below content and/or in the footer below. 

  • Products
  • Therapy Area
  • Resources
  • Events & Webinars
  • Learning Zone
  • Podcasts

Ophthalmology Events & On Demand Webinars

Discover Events & On Demand Webinars below that you can access to learn more about EYLEA 8mg in neovascular (wet) age-related macular degeneration (nAMD) and diabetic macular oedema (DME).​

Expert Opinion
|
Clinical Perspective
|
ICO Symposium 2024 - Highlights
|
ICO Symposium 2024 - Series of Short Videos

Expert opinion on high molar dose and early experience of Eylea
®
8mg

Watch

Dr. Peter Kaiser,
Cole Eye Institute, Cleveland Clinic, discuss his perspective on higher molar dose.

Watch

Dr. John Kitchens,
Retina Associates of Kentucky, discuss his early experience with Eylea 8mg.

Clinician Perspective on Eylea® 8mg with Dr. Kenneth Fan

Case spotlight with EYLEA 8mg: treatment-naïve patient with DME

-

Dr Kenneth Fan,
Retina Consultants of Texas, USA

Learnings from one year with EYLEA 8mg in the clinic

-

Dr Kenneth Fan,
Retina Consultants of Texas, USA

ICO Symposium 2024 - Highlights

Bayer ICO 2024 Highlights - Early Experience in the treatment of AMD by

Dr. Michael Stewart, MD
, Chairman of Ophthalmology, Knights Templar Eye Foundation, Inc. Professor of Ophthalmology Research Mayo Clinic Florida.

Bayer ICO 2024 Highlights - Insights from the Experts by

Dr. Michael Stewart, MD
&
Professor Richard Gale

ICO Symposium 2024 - Series of Short Videos with Dr. Michael Stewart & Professor Richard Gale

Experience with EYLEA 8mg treating naive DME patients vs. previously treated DME patients

How does Eylea 8mg prolong duration of action?

Place of EYLEA 8mg in treating DME and the issue of injection volume

Prescribing information for EYLEA® (aflibercept) can be found here:

EYLEA® Prescribing Information

PP-EYL_8mg-IE-0161-1   |   January 2026